NCT02117817 2022-07-28Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian CancerRutgers, The State University of New JerseyPhase 1 Withdrawn
NCT01068483 2020-12-08Safety of BKM120 Monotherapy in Advanced Solid Tumor PatientsNovartisPhase 1 Completed107 enrolled